International Edition
Latest News
Health

Twelve Months of LLLT Show Sustained Benefit in Alopecia

Summary of the Low-Level Laser Therapy (LLLT) Study for Androgenetic Alopecia (AGA) This text details the results of a 12-month study investigating the efficacy and safety of Low-Level Laser Therapy (LLLT) for Androgenetic Alopecia (AGA), commonly known as…

Twelve Months of LLLT Show Sustained Benefit in Alopecia

Summary of the Low-Level Laser Therapy (LLLT) Study for Androgenetic Alopecia (AGA)

This text details the results of a 12-month study investigating the efficacy and safety of Low-Level Laser Therapy (LLLT) for Androgenetic Alopecia (AGA), commonly known as pattern baldness. Here’s a breakdown of the key findings:

Key Results:

* Increased Hair Density: A significant increase in hair density was observed, rising from approximately 99 hairs/cm at baseline to 124 hairs/cm at 48 weeks – a roughly 25% increase. improvements were statistically significant from 16 weeks and continued throughout the year.
* Improved Hair Shaft Thickness: Hair shaft thickness also increased, from about 65 µm to nearly 75 µm (approximately 15% increase). Improvements in thickness became statistically significant around 24 weeks.
* Positive Clinical & Patient Assessments: Nearly 59% of participants showed improvement based on investigator global photographic assessments, and over 98% showed stabilization or improvement. Over 85% of patients reported satisfaction and willingness to continue treatment.
* Excellent Safety Profile: No device-related adverse events were reported, with no scalp irritation, burns, or systemic effects.
* High Adherence: Average treatment adherence was over 97%, likely due to the convenience of the device and lack of side effects.
* Consistent Response Across Subgroups: Both men and women, and patients with varying degrees of AGA severity (mild, moderate, severe) experienced measurable improvements.

Limitations:

* Open-Label Design: The study lacked a sham control group, raising the possibility of placebo effects.
* Single Device: Results may not be generalizable to all LLLT systems.

Clinical Implications:

* LLLT can provide sustained, incremental improvements in hair density and thickness over 12 months with a good safety profile.
* It’s not a replacement for conventional pharmacologic therapies but can be a valuable option for patients who cannot tolerate or prefer to avoid systemic medications, or as an addition to existing treatments.
* LLLT is best viewed as a long-term maintenance therapy for AGA, given the chronic nature of the condition.

In essence, the study suggests LLLT is a safe and perhaps effective long-term treatment option for AGA, offering consistent, though modest, improvements in hair density and thickness.

About the author: Dr Natalie Singh - Health Editor

Board‑certified internal‑medicine physician and MPH. Natalie authored peer‑reviewed studies on infectious disease and served as medical editor. “Dr. Natalie Singh delivers evidence‑based health news, medical breakthroughs, and expert wellness guidance.”